Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2025-12-26 @ 10:15 PM
Study NCT ID:
NCT01102803
Status:
COMPLETED
Last Update Posted:
2013-02-21
First Post:
2010-04-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for Acrophobia
Sponsor:
Southern Methodist University
Organization:
Study Overview
Official Title:
Evaluation of the Effects of Post-Session Administration of D-cycloserine On Exposure Therapy Outcomes
Status:
COMPLETED
Status Verified Date:
2012-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the utility of post-session administration of D-cycloserine to enhance fear extinction in a sample of people with acrophobia who will be treated with CBT.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: